Effective treatments of the singular line boundary problem for threedimensional grids

1992 ◽  
Author(s):  
GRANT PALMER ◽  
ETHIRAJ VENKATAPATHY
AIAA Journal ◽  
1993 ◽  
Vol 31 (10) ◽  
pp. 1757-1758
Author(s):  
Grant Palmer ◽  
Ethiraj Venkatapathy

2017 ◽  
Vol 19 (9.2) ◽  
pp. 55-62
Author(s):  
I.A. Vlasova

In the work the general properties of equations of spatial problem of the theory of ideal plasticity in the condition of Treska plasticity and stressed state that correspond to the ridge of surface of fluctuation are viewed. Singular lines in hard plastic space and solutions in the neighborhood of a singular line that are similar to the expansion in beam series are viewed. On the basis of the developed theory the boundary problem appearing at indentation of punch with smooth basis in a certain plastic body which in the simplest case is a half-space is solved.


Author(s):  
Peter Tyrer ◽  
Kenneth R. Silk
Keyword(s):  

MAT Serie A ◽  
2001 ◽  
Vol 5 ◽  
pp. 37-41
Author(s):  
Claudia Lederman ◽  
Juan Luis Vázquez ◽  
Noemí Wolanski

2019 ◽  
Vol 25 (39) ◽  
pp. 5327-5346 ◽  
Author(s):  
Konstantin P. Volcho ◽  
Sergey S. Laev ◽  
Ghulam Md Ashraf ◽  
Gjumrakch Aliev ◽  
Nariman F. Salakhutdinov

Neurodegenerative disorders (NDDs) like Alzheimer's disease, Parkinson’s disease and Huntington’s disease are a heterogeneous group of disorders with the progressive and severe loss of neurons. There are no full proof cures for these diseases, and only medicines are available that can alleviate some of the symptoms. Developing effective treatments for the NDDs is a difficult but necessary task. Hence, the investigation of monoterpenoids which modulate targets applicable to many NDDs is highly relevant. Many monoterpenoids have demonstrated promising neuroprotective activity mediated by various systems. It can form the basis for elaboration of agents which will be useful both for the alleviation of symptoms of NDDs and for the treatment of diseases progression and also for prevention of neurodegeneration. The further developments including detections of monoterpenoids and their derivatives with high neuroprotective or neurotrophic activity as well as the results of qualified clinical trials are needed to draw solid conclusions regarding the efficacy of these agents.


Sign in / Sign up

Export Citation Format

Share Document